Krystal Biotech (STU:4KB) Other Net Income (Loss) : €-1.80 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Krystal Biotech Other Net Income (Loss)?

Krystal Biotech's Other Net Income (Loss) for the three months ended in Mar. 2024 was €0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.80 Mil.

Krystal Biotech's quarterly Other Net Income (Loss) declined from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-1.80 Mil) but then increased from Dec. 2023 (€-1.80 Mil) to Mar. 2024 (€0.00 Mil).

Krystal Biotech Other Net Income (Loss) Historical Data

The historical data trend for Krystal Biotech's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krystal Biotech Other Net Income (Loss) Chart

Krystal Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Krystal Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-1.80	-

Krystal Biotech Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.80 Mil.

Krystal Biotech Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Krystal Biotech's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Krystal Biotech (STU:4KB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Krystal Biotech Inc (STU:4KB) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

KRYS:USA

Address

2100 Wharton Street, Suite 701, Pittsburgh, PA, USA, 15203

Website

https://www.krystalbio.com

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

Krystal Biotech (STU:4KB) Headlines

No Headlines